MarketCap
Facebook
X
Telegram
CVR Partners, LP Financial Ratios 2025-2011 | UAN
Brief overview of CVR Partners, LP's valuation and returns
The comparison uses the five latest available annual observations between 2021 and 2025.
The current valuation set is P/E 11.77x (median 10.89x), EV/EBITDA 3.52x (median 34.72x), P/S 1.92x (median 1.6x). Multiples are on average 19.8% above their own medians. A substantial share of positive expectations may already be priced in.
Earnings yield calculated as 1/P/E is about 8.5%, showing current profit per unit of share price.
Capital efficiency is characterized by ROE 37.1%, ROA 10.2%, ROCE 14.7%. Business quality is high on return ratios, supporting the ability to create value.
PEG is 0.12x. Price is low relative to embedded growth, though the ratio depends heavily on forecast quality.
The cash cycle lengthened by 22.8 days to 102.6 days. Operations require more funding.
Valuation takeaway
CVR Partners, LP demonstrates high business quality but trades at a premium to its own history. Strong future results are needed to preserve valuation.
Annual Financial Ratios CVR Partners, LP
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
11.8 | 14.1 | 4.3 | 3.7 | 10.9 | -1.7 | -89.4 | -81.7 | -54.5 | -249.6 | 64.1 | 112.4 | 109.5 | 180.1 | 158.2 |
P/S |
1.9 | 1.6 | 1.1 | 1.3 | 1.6 | 0.5 | 7.7 | 11.6 | 12.0 | 18.9 | 13.8 | 28.7 | 40.1 | 66.9 | 69.1 |
EPS |
9.3 | 5.8 | 16.3 | 27.1 | 7.3 | -8.8 | -3.1 | -0.4 | -0.6 | -0.3 | 0.8 | 1.0 | 1.6 | 1.5 | 1.5 |
EV (Enterprise Value) |
1.09 B | 765 M | 692 M | 982 M | 739 M | 137 M | 3.81 B | 4.78 B | 4.6 B | 7.36 B | 4.08 B | 8.64 B | 13.1 B | 20.3 B | 20.9 B |
EBITDA per Share |
19.9 | 16.9 | 26.6 | 38 | 19.5 | 3.68 | 0.946 | 0.688 | 0.562 | 0.775 | 1.33 | 1.5 | 2.06 | 1.86 | 2.12 |
EV/EBITDA |
3.5 | 3.6 | 34.7 | 59.8 | 71.3 | 91.1 | 41.7 | 78.2 | 86.5 | 148.0 | 134.3 | ||||
PEG |
0.12 | 0.09 | 0.03 | 0.02 | 0.07 | -0.03 | -2.97 | -2.61 | 0.37 | 1.91 | -3.46 | -3.14 | 19.2 | -11.72 | -2.62 |
P/B |
1.2 | 0.8 | 0.8 | 1.0 | 0.8 | 0.2 | 7.5 | 8.2 | 7.2 | 10.8 | 10.3 | 20.7 | 29.5 | 45.3 | 42.8 |
P/CF |
7.8 | 5.7 | 3.0 | 3.5 | 4.5 | 8.5 | 152.5 | 329.1 | -954.0 | 309.4 | 64.8 | 87.5 | 152.4 | 394.0 | 173.4 |
ROE % |
37.13 | 20.78 | 56.93 | 69.64 | 22.84 | -31.24 | -8.34 | -10.01 | -13.24 | -4.31 | 16.09 | 18.40 | 26.96 | 25.15 | 27.05 |
ROA % |
10.18 | 5.98 | 17.68 | 26.06 | 6.93 | -9.51 | -3.07 | -3.99 | -5.90 | -2.05 | 11.57 | 13.16 | 19.98 | 18.01 | 20.08 |
ROCE % |
14.74 | 9.96 | 22.38 | 32.83 | 13.93 | -10.74 | 2.58 | 0.56 | -0.87 | 1.75 | 13.47 | 15.36 | 22.06 | 20.19 | 22.08 |
Current Ratio |
- | - | - | - | - | - | 1.7 | 1.6 | 2.1 | 2.1 | 3.8 | 3.3 | 5.0 | 3.4 | 6.4 |
DSO |
37.4 | 37.2 | 35.4 | 39.1 | 42.9 | 37.1 | 30.9 | 64.1 | 10.9 | 14.3 | 9.1 | 8.7 | 8.5 | 8.2 | 11.2 |
DIO |
65.2 | 65.0 | 59.6 | 49.0 | 46.6 | 54.0 | 73.5 | 93.6 | 81.9 | 87.7 | 80.0 | 76.1 | 79.4 | 74.4 | 65.9 |
DPO |
- | - | - | - | 9.6 | 22.8 | 32.2 | 43.8 | 35.6 | 43.4 | 23.7 | 27.2 | 41.0 | 87.8 | 45.0 |
Operating Cycle |
102.6 | 102.2 | 95.1 | 88.1 | 89.5 | 91.2 | 104.5 | 157.7 | 92.7 | 102.0 | 89.1 | 84.8 | 87.8 | 82.7 | 77.1 |
Cash Conversion Cycle |
102.6 | 102.2 | 95.1 | 88.1 | 79.9 | 68.4 | 72.2 | 113.9 | 57.1 | 58.5 | 65.4 | 57.6 | 46.8 | -5.2 | 32.1 |
All numbers in USD currency
Quarterly Financial Ratios CVR Partners, LP
| 2026-Q1 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
4.72 | 3.67 | 2.56 | 0.36 | 2.48 | 1.19 | 0.07 | 5.66 | 9.64 | - | -1.87 | 11.12 | 8.78 | - | 3.28 | 0.66 | -2.37 | - | -1.7 | -3.68 | -1.83 | -0.22 | -0.2 | 0.17 | -0.05 | -0.01 | -0.12 | -0.15 | -0.17 | -0.24 | -0.28 | -0.03 | -0.09 | -0.13 | -0.12 | -0.15 | 0.25 | 0.26 | -0.18 | 0.37 | 0.41 | 0.34 | 0.17 | 0.23 | 0.29 | 0.38 | 0.27 | 0.48 | 0.49 | 0.21 | 0.43 | 0.48 | 0.41 | 0.56 | 0.5 | 0.42 | - |
EBITDA per Share |
7.34 | 6.36 | 4.98 | 3.38 | 5.07 | 3.72 | 3.05 | 8.18 | 11.8 | - | 0.96 | 13.9 | 11.6 | - | 5.97 | 4.82 | 0.01 | - | 1.34 | -0.21 | 0.94 | -0.08 | 0.1 | 0.53 | 0.23 | 0.07 | 0.16 | 0.17 | 0.11 | 0.07 | 0.02 | 0.28 | 0.18 | 0.16 | 0.17 | 0.19 | 0.36 | 0.38 | -0.06 | 0.49 | 0.52 | 0.46 | 0.29 | 0.35 | 0.41 | 0.5 | 0.38 | 0.59 | 0.58 | 0.29 | 0.51 | 0.56 | 0.5 | 0.65 | 0.58 | 0.6 | - |
ROE % |
38.56 | 31.19 | 23.17 | 14.42 | 30.09 | 46.75 | 36.61 | 30.47 | 38.97 | 45.07 | 45.07 | 50.98 | 25.49 | - | - | - | - | -5.93 | -11.86 | -11.86 | -5.93 | -6.21 | -0.55 | -0.55 | -0.27 | -5.26 | -9.97 | -9.97 | -4.98 | -7.31 | -4.65 | -4.65 | 2.37 | 7.07 | 14.26 | 5.88 | 12.50 | 15.52 | 16.66 | 23.41 | 20.94 | 18.40 | 18.74 | 20.15 | 24.06 | 26.96 | 24.05 | 26.65 | 26.45 | 25.15 | 30.14 | 30.48 | 30.42 | 27.06 | 7.41 | 7.81 | 3.42 |
ROA % |
11.84 | 9.67 | 7.08 | 4.48 | 9.97 | 16.37 | 13.24 | 11.34 | 13.96 | 15.16 | 18.44 | 15.05 | 15.74 | 1.51 | -0.33 | -5.44 | -10.16 | -7.87 | -10.06 | -10.24 | -4.55 | -3.07 | -1.00 | -0.02 | -3.00 | -3.99 | -6.10 | -7.61 | -6.58 | -5.90 | -4.79 | -3.25 | -4.27 | -2.05 | 2.55 | 1.06 | 7.39 | 11.57 | 12.37 | 17.08 | 15.00 | 13.16 | 13.57 | 14.69 | 17.70 | 19.99 | 17.74 | 19.49 | 19.15 | 18.01 | 21.80 | 22.24 | 22.41 | 20.09 | 5.50 | 5.80 | 2.54 |
ROCE % |
16.29 | 13.75 | 11.00 | 8.12 | 13.89 | 21.07 | 17.49 | 15.27 | 35.55 | 37.16 | 44.38 | 52.93 | 30.26 | 9.68 | 9.20 | 1.49 | -7.15 | -5.27 | -6.12 | -6.81 | 2.57 | 4.82 | 6.38 | 7.95 | 2.45 | 0.44 | -1.19 | -4.29 | -2.22 | -0.83 | 0.16 | 3.25 | 1.90 | 3.00 | 6.91 | 4.13 | 8.92 | 13.14 | 14.06 | 19.14 | 17.24 | 15.36 | 15.69 | 16.78 | 19.84 | 22.06 | 19.59 | 21.47 | 21.21 | 20.19 | 24.31 | 24.75 | 24.84 | 22.08 | 6.08 | 6.38 | 2.72 |
DSO |
26.2 | 24.9 | 24.8 | 30.6 | 29.3 | 26.2 | 24.5 | 21.6 | 28.9 | - | 15.9 | 8.2 | 27.0 | - | 21.4 | 16.6 | 39.2 | - | 42.4 | 32.0 | 43.2 | 36.3 | 35.3 | 22.7 | 47.6 | 57.4 | 70.4 | 60.4 | 40.9 | 11.5 | 13.0 | 9.2 | 12.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
65.7 | 61.8 | 70.7 | 66.6 | 75.0 | 66.6 | 61.4 | 69.3 | 68.5 | - | 18.5 | 26.8 | 48.7 | - | 54.3 | 48.7 | 65.8 | - | 49.3 | 45.3 | 55.4 | - | 50.3 | 45.6 | 67.9 | - | 81.7 | 66.7 | 68.7 | 59.6 | 62.3 | 61.8 | 70.1 | 69.2 | 77.1 | 49.3 | 92.8 | 85.6 | 62.2 | 72.0 | 58.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | 30.3 | - | 20.6 | 20.2 | 37.6 | - | 32.8 | 21.7 | 26.6 | - | 22.8 | 20.9 | 24.8 | - | 21.9 | 19.9 | 29.1 | - | 34.5 | 28.1 | 28.3 | 23.7 | 25.8 | 26.9 | 32.7 | 34.3 | 38.2 | 24.4 | 38.7 | 25.3 | 18.4 | 21.3 | 19.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
91.9 | 86.7 | 95.5 | 97.3 | 104.4 | 92.8 | 85.9 | 90.9 | 97.4 | - | 34.4 | 35.0 | 75.7 | - | 75.6 | 65.4 | 105.1 | - | 91.7 | 77.3 | 98.6 | 36.3 | 85.6 | 68.3 | 115.6 | 57.4 | 152.1 | 127.0 | 109.5 | 71.1 | 75.3 | 71.0 | 82.8 | 69.2 | 77.1 | 49.3 | 92.8 | 85.6 | 62.2 | 72.0 | 58.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
91.9 | 86.7 | 95.5 | 97.3 | 104.4 | 92.8 | 85.9 | 90.9 | 67.0 | - | 13.8 | 14.7 | 38.1 | - | 42.8 | 43.7 | 78.5 | - | 68.9 | 56.4 | 73.8 | 36.3 | 63.7 | 48.4 | 86.5 | 57.4 | 117.7 | 98.9 | 81.2 | 47.4 | 49.5 | 44.1 | 50.1 | 34.9 | 38.9 | 24.9 | 54.1 | 60.2 | 43.8 | 50.7 | 39.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company CVR Partners, LP, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Financial Ratios of other stocks in the Agricultural inputs industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
Акрон
AKRN
|
- | - | - |  Russia |
 |
The Mosaic Company
MOS
|
$ 22.3 | 0.09 % | $ 7.08 B |  USA |
 |
ФосАгро
PHOR
|
- | - | - | Russia |
 |
China Green Agriculture
CGA
|
- | 0.51 % | $ 27.6 M |  China |
 |
The Scotts Miracle-Gro Company
SMG
|
$ 69.31 | 2.64 % | $ 3.99 B | USA |
 |
American Vanguard Corporation
AVD
|
$ 2.57 | 1.58 % | $ 73.1 M | USA |
 |
CF Industries Holdings
CF
|
$ 125.07 | -1.29 % | $ 20.3 B | USA |
 |
FMC Corporation
FMC
|
$ 11.3 | -3.38 % | $ 1.41 B | USA |
 |
Marrone Bio Innovations
MBII
|
- | -5.9 % | $ 180 M | USA |
 |
Yield10 Bioscience
YTEN
|
- | 15.32 % | $ 46.6 M | USA |
 |
Bioceres Crop Solutions Corp.
BIOX
|
$ 0.34 | -1.44 % | $ 21.5 M |  Argentina |
 |
Corteva
CTVA
|
$ 89.25 | 0.53 % | $ 60.7 B | USA |
 |
Origin Agritech Limited
SEED
|
$ 1.01 | 1.0 % | $ 7.57 M | China |
 |
ICL Group Ltd
ICL
|
$ 5.28 | -0.38 % | $ 6.81 B |  Israel |
 |
Arcadia Biosciences
RKDA
|
$ 0.64 | 2.89 % | $ 876 K | USA |
 |
Intrepid Potash
IPI
|
$ 34.22 | -0.67 % | $ 445 M | USA |
 |
Nutrien Ltd.
NTR
|
$ 68.1 | -0.64 % | $ 33.1 B |  Canada |